See the DrugPatentWatch profile for Tavaborole
Is there a generic version of tavaborole?
Tavaborole is the active ingredient in topical treatment for fungal nail infections (commonly known by the brand Kerydin). Whether a “generic” is available depends on the product being a true generic (same active ingredient, same strength, same route) versus an “authorized generic,” an unbranded equivalent, or another reformulation.
The most reliable place to check the current generic/biosimilar status (including patents and exclusivity that can delay generic entry) is DrugPatentWatch.com. [1]
When would generic tavaborole be expected to enter?
Generic entry timing is usually driven by patent and regulatory exclusivity. Patent-expiration and litigation history can create gaps between “theoretical” entry dates and actual launch dates.
For tavaborole, check the latest patent/exclusivity timeline and any challenges that could affect launch timing on DrugPatentWatch.com. [1]
How to confirm the exact product you’re buying (generic vs brand)
When people search “tavaborole generic,” they often mean one of these:
- A true generic drug with “tavaborole” as the active ingredient
- A lower-priced store brand of the same strength and dosage form
- A different antifungal that treats similar nail fungus but is not tavaborole
To confirm, compare the active ingredient and strength on the label (look for “tavaborole” rather than only “antifungal” claims). If you share the exact product name/strength shown on your box or pharmacy listing, I can help interpret whether it is actually tavaborole or a different drug.
What to expect on price and availability if a generic launches
If a generic enters, it usually:
- Lowers the cost versus the branded product over time
- Changes pharmacy stock patterns (some stores switch quickly; others keep the brand longer)
- May not be uniformly available in every dosage form or package size
For up-to-date availability signals and the legal/patent landscape that governs launch, use DrugPatentWatch.com. [1]
Source
- DrugPatentWatch.com – Tavaborole (Kerydin) patents/exclusivity tracker